Highlight of this talk

• Describe the interplay between diabetes, cardiovascular disease and renal disease
• Examine current treatment paradigms in cardiovascular disease and strategies in improving patient outcomes
• Describe the novel data around SGLT-2 inhibitors in improving outcomes in patients with diabetes and cardiac and renal disease

Speaker

Dr Hussain Contractor
Consultant Interventional Cardiologist at
Manchester University NHS Foundation Trust

Chairperson

Dr Jane Wilcock
GP, Clinical advisor RCGP, Chair overdiagnosis group RCGP, Vicechair NWE faculty RCGP

Awarded 1 CPD Credit